Advertisement

Cancer: A Problem in Somatic Cell Evolution

  • John Leslie Collins
  • Paul Q. Patek
  • Melvin Cohn
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 11)

Abstract

Our goal is to define steps required for a cell to grow as a cancer. The complexity of the factors involved in the development of cancer make it clear that the analysis of clinical malignancy will not reveal these steps. Since these steps cannot be analyzed at the single cell level in vivo we extrapolate from the experimental to the autochthonous situation using a theory that considers the development of cancer to be a problem in somatic cell evolution.

Keywords

Natural Killer Activity Associative Recognition Anchorage Independence Restricting Element Anchorage Dependence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Algire, G. H., Weaver, J. M., and Prehn, R. T., 1954, Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice, J. Natl. Cancer Inst. 15: 493.PubMedGoogle Scholar
  2. Anderson, R. E., Lefkovits, L, and Troup, G. M., 1980, Radiation-induced augmentation of the immune response, in: Current Topics in Immunobiology, Vol. 11 ( N. L. Warner, ed.), pp. 245–274, Plenum Press, New York.Google Scholar
  3. Argyris, B. F., 1978, Activation of suppressor cells by syngeneic tumor transplants in mice, Cancer Res. 38: 1269–1273.PubMedGoogle Scholar
  4. Baker, P. J., Stashad, P. W., Amsbaugh, D. F., and Prescott, B., 1974, Regulation of the antibody response to type III pneumococcal polysaccharide. III. Mode of action of thymic-derived suppressor cells, J. Immunol. 112: 404–409.PubMedGoogle Scholar
  5. Baldwin, R. W., 1973, Immunological aspects of chemical carcinogensis, in: Advances in Cancer Research ( G. Klein and S. Weinhouse, eds.), Vol. 18, pp. 1–75, Academic Press, New York.Google Scholar
  6. Baldwin, R. W., and Robins, R. A., 1977, Induction of tumor-immune responses and their interaction with the developing tumor, in: Contemporary Topics in Molecular Immunology, Vol. 6 ( R. R. Porter and G. L. Ada, eds.), pp. 177–207, Plenum Press, New York.Google Scholar
  7. Basombrio, M. A., 1970, Search for common antigenicities among twenty five sarcomas induced by methylcholanthrene, Cancer Res. 30: 2458–2462.PubMedGoogle Scholar
  8. Basombrio, M. A., and Prehn, R. T., 1972a, Studies on the bases for diversity and time of appearance of antigens in chemically induced tumors, in: National Cancer Institute Monographs ( M. F. Stanton, ed.), pp. 117–124, Department of Health, Education and Welfare.Google Scholar
  9. Basombrio, M. A., and Prehn, R. T., 1972b, Antigenic diversity of tumor schemically induced within the progeny of a single cell, Int. J. Cancer 10: 1–8.PubMedCrossRefGoogle Scholar
  10. Basombrio, M. A., and Prehn, R. T., 1972c, Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors, Cancer Res. 32: 2545–2550.PubMedGoogle Scholar
  11. Berker, F. F., 1975, in: Etiology: Chemical and Physical Carcinogenesis (F. Becker, ed.), Plenum Press, New York.Google Scholar
  12. Bevan, M. J., 1975a, The major histocompatibility complex determines susceptibility to cytotoxic T-cells directed against minor histocompatibility antigen, J. Exp. Med. 142: 1349–1364.PubMedCrossRefGoogle Scholar
  13. Bevan, M. J., 1975b, Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors, J. Immunol. 114: 316–319.PubMedGoogle Scholar
  14. Bevan, M. J., and Hyman, R., 1977, The ability of H-2* and H-2- cell lines to induce or be lysed by cytotoxic T cells, Immunogenetics 4: 7–16.CrossRefGoogle Scholar
  15. Bevan, M. J., Langman, R. E., and Cohn, M., 1976, H-2 antigen-specific cytotoxic T cells induced by concanavalin A: Estimation of their relative frequency, Eur. J. Immunol. 6: 150–156.PubMedCrossRefGoogle Scholar
  16. Boone, C. W., 1975, Malignant hemangioendotheliomas produced by subcutaneous inoculation of BALB/3T3 cells attached to glass beads, Science 188: 68–70.PubMedCrossRefGoogle Scholar
  17. Bouck, N., and DiMayorca, G., 1976, Somatic mutation as the basis for malignant transfor-mation of BHK cells by chemical carcinogens, Nature (London) 264: 722–727.CrossRefGoogle Scholar
  18. Bretscher, P., 1972, The control of humoral and associative antibody synthesis, Transplant. Rev. 11: 217–267.Google Scholar
  19. Bretscher, P., 1973, Hypothesis: A model for generalized autoimmunity, Cell. Immunol. 6: 1–11.PubMedCrossRefGoogle Scholar
  20. Bretscher, P., 1974, Hypothesis: On the control between cell-mediated, IgM and IgG immunity, Cell. Immunol. 13: 171–195.PubMedCrossRefGoogle Scholar
  21. Bretscher, P., 1977, An integration of B and T-lymphocytes in immune activation, in: B and T Cells in Immune Recognition ( F. Loor and G. E. Roelants, eds.), pp. 457–485, Wiley, New York.Google Scholar
  22. Bretscher, P., and Cohn, M., 1970, A theory of self-nonself discrimination, Science 169: 1042–1049.PubMedCrossRefGoogle Scholar
  23. Cantor, H., and Boyse, E. A., 1975, Functional subclass of T lymphocytes bearing different Ly antigens. I. The generation of functional distinct T-cell subclass in a differentiative process independent of antigen, J. Exp. Med. 141: 1376.PubMedCrossRefGoogle Scholar
  24. Cimprich, R. S., Spector, S., and Freidman, H., 1978, Murine lymphoma-induced immunosuppression: Requirement for direct tumor cell contact, Science 200: 60–61.PubMedCrossRefGoogle Scholar
  25. Coggin, J. H., and Anderson, N. G., 1974, Cancer, differentiation and embryonic antigens: Some central problems, in: Advances in Cancer Research ( G. Klein and S. Weinhouse, eds.), Vol. 19, pp. 106–165, Academic Press, New York.Google Scholar
  26. Cohn, M., 1971, The take home lesson, Ann. N.Y. Acad. Sci. 190: 529–585.PubMedCrossRefGoogle Scholar
  27. Cohn, M., 1972, in: Genetic Control of Immune Responsiveness (H. O. McDevitt and M. Landy, eds.), pp. 370–451, Academic Press, New York.Google Scholar
  28. Cohn, M., 1975a, The logic of cell interactions in determining immune responsiveness, in: Approaches to Immunology ( E. E. Smith and D. W. Ribbons, eds.), pp. 79–107, Academic Press, New York.Google Scholar
  29. Cohn, M., 1975b, in: Immunobiology of the Tumor Host Relationship (R. T. Smith and M. Landy, eds.), pp. 249–253, Academic Press, New York.Google Scholar
  30. Cohn, M., 1976, Summary discussion of directions of immunobiology, in: Mitogens in Immunology ( J. J. Oppenheim and D. L. Rosenstreich, eds.), pp. 663–702, Academic Press, New York.Google Scholar
  31. Cohn, M., and Blomberg, B., 1975, The self-nonself discrimination: A one-or two-signal mechanism, Scand. J. Immunol. 4: 1–24.PubMedCrossRefGoogle Scholar
  32. Cohn, M., and Epstein, R., 1978, T-cell inhibition of humoral responsiveness. II. Theory of the role of restrictive recognition in immune regulation, Cell. Immunol. 39: 125–153.PubMedCrossRefGoogle Scholar
  33. Colburn, N. H., Vorder-Bruegge, W. F., Bates, J. R., Gray, R. H., Rossen, J. D., Kelsey, W. H., and Shimada, T., 1978, Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells, Cancer Res. 38: 624–634.PubMedGoogle Scholar
  34. Collins, J. C., Patek, P. Q., and Cohn, M., 1980, The relationship of tumorigenicity to NK recognition and lysis, J. Exp. Med. (submitted manuscript).Google Scholar
  35. Crewther, P., and Warner, N. L., 1972, Serum immunoglobulin and antibodies in congenitally athymic (nude) mice, Aust. J. Exp. Biol. Med. 50: 625–635.CrossRefGoogle Scholar
  36. Croce, C. M., 1977, Assignment of the integration site for Simian virus 40 to chromosome 7 in GM54VA, a human cell line transformed by Simian virus 40, Proc. Natl. Acad. Sci. U.S.A. 74: 315–318.PubMedCrossRefGoogle Scholar
  37. Croce, C. M., and Koprowski, H., 1974, Somatic cell hybrids between mouse peritoneal macrophages and SV40 transformed human cells. I. Positive control of the transformed phenotype by the human chromosome 7 carrying the SV40 genome, J. Exp. Med. 140: 1221–1229.PubMedCrossRefGoogle Scholar
  38. Daynes, R. A., Schmitt, M. K., Roberts, L. K., and Spellman, C. W., 1979, Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV-induced tumors, J. Immunol. 122: 2458–2464.PubMedGoogle Scholar
  39. DeMars, R., 1977, Comments about the paper by Norwood et al. and an idea relating somatic cell mutations to cellular senescence, in: Senescence (W. W. Nichols and D. G. Murphy, eds.), pp. 39–55, Plenum Press, New York.Google Scholar
  40. DiPaolo, J. A., Nelson, R. L., and Donovan, P. J., 1969, Sarcoma-producing cell lines de- rived from clones transformed in vitro by Benzo[a] pyrene, Science 165: 917–919.PubMedCrossRefGoogle Scholar
  41. DiPaolo, J. A., Nelson, R. L., and Donovan, P. J., 1971, Morphological, oncogenic, and karyological characteristics of Syrian hamster embryo cells transformed in vitro by carcinogenic polycyclic hydrocarbons, Cancer Res. 31: 1118–1127.PubMedGoogle Scholar
  42. Eggers, A. E., and Wunderlich, J. R., 1975, Suppression cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens, J. Immunol. 114: 1554–1562.PubMedGoogle Scholar
  43. Eisen, H. N., Sakato, N., and Hall, S. J., 1975, Myeloma proteins as tumor specific antigens, Transplant. Proc. 7: 209–214.PubMedGoogle Scholar
  44. Elgert, K. D., and Farrar, W. L., 1978, Suppressor cell activity in tumor-bearing mice. I Dualistic inhibition by suppressor T lymphocytes and macrophages, J. Immunol 120: 1345–1353.PubMedGoogle Scholar
  45. Embleton, M. J., and Heidelberger, C., 1972, Antigenicity of clones of mouse prostate cells transformed in vitro, Int. J. Cancer 9: 8–18.PubMedCrossRefGoogle Scholar
  46. Fenjo, E. M., Klein, E., Klein, G., and Swiech, K., 1968, Selection of an immunoresistant Moloney lymphoma sublime with decreased concentration of tumor-specific surface antigens, J. Natl. Cancer Inst. 40: 69–89.Google Scholar
  47. Fisher, M. S., and Kripke, M. L., 1978, Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation, J. Immunol 121: 1139–1144.PubMedGoogle Scholar
  48. Fortner, G. W., and Kripke, M. L., 1977, In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors, J. Immunol. 118: 1483–1487.Google Scholar
  49. Freedman, V. H., and Shin, S., 1977, Isolation of human diploid cell variants with enhanced colony-forming efficiency in semisolid medium after a single-step chemical mutagenesis: Brief communication, J. Natl. Cancer Inst. 58: 1873–1875.PubMedGoogle Scholar
  50. Fujimoto, S., Greene, M., and Sehon, A. H., 1975, Immunosuppressor T cells in tumor bearing hosts, Immunol. Commun. 4: 201–217.PubMedGoogle Scholar
  51. Gee, C. J., and Harris, H., 1979, Tumorigenicity of cells transformed by Simian virus 40 and hybrids between such cells and normal diploid cells, J. Cell Sci. 36: 223–240.PubMedGoogle Scholar
  52. Gleichman, E., Gleichman, H., and Schwartz, R. S., 1972, Immunologic induction of malignant lymphoma: Genetic factors in the graft versus host model, J. Natl. Cancer Inst. 49: 793–804.Google Scholar
  53. Graham, S. D., Mickey, D. D., and Paulson, D. F., 1978, Detection of metastatic tumors in nude mice: Brief communication, J. Natl. Cancer Inst. 60: 715–716.PubMedGoogle Scholar
  54. Green, I., Cohen, S., and McClusky, R. T. (eds.), 1977, Mechanisms of Tumor Immunity, Wiley, New York.Google Scholar
  55. Greene, M. L, Dorf, M. E., Pierres, M., and Benacerraf, B., 1977, Reduction of syngeneic tumor growth by anti-I-J alloantiserum, Proc. NatL Acad. Sci. U.S.A. 74: 5118–5121.PubMedCrossRefGoogle Scholar
  56. Haller, O., Hansson, M., Kiessling, R., and Wigzell, H., 1977, Role of non conventional natural killer cells in resistance against syngeneic tumor cells in vivo, Nature (London) 270: 609–611.CrossRefGoogle Scholar
  57. Harrison, D. E., 1979, Mouse erythropoietic cell lines function normally 100 month: Loss related to number of transplantations, Mech. Ageing Dev. 9: 427–433.PubMedCrossRefGoogle Scholar
  58. Hayflick, L., 1965, The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res. 37: 614–636.PubMedCrossRefGoogle Scholar
  59. Hayflick, L., 1979, Cell aging, in: Physiology and Cell Biology of Aging (A. Cherkin, N. Kharasch, F. L. Scott, C. E. Finch, T. Makinodan, and B. Strehler, eds.) Aging, Vol. 8), pp. 3–19, Raven Press, New York.Google Scholar
  60. Hayflick, L., and Moorhead, P., 1961, The serial cultivation of human diploid cell strains, J. Cell Biology 62: 48–53.Google Scholar
  61. Hays, E. F., 1972, Graft-versus-host reactions and the viral induction of mouse lymphoma, Cancer Res. 32: 270–275.PubMedGoogle Scholar
  62. Hellström, K. E., and Hellström, I., 1970, Immunological enhancement as studied by cell culture techniques, in: Annual Review of Microbiology, Vol. 24 ( C. E. Clifton, ed.), pp. 373–398, Annual Reviews, Palo Alto, Calif.Google Scholar
  63. Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol. 18: 209–277.PubMedCrossRefGoogle Scholar
  64. Hellström, K. E., and Hellström, I., 1975, A role of blocking serum factors in immunity to embryonic tumor antigens, in: Critical Factors in Cancer Immunology ( J. Schultz and R. C. Leef, eds.), pp. 211–229, Academic Press, New York.Google Scholar
  65. Hellström, K. E., and Hellström, I., 1978, Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population, Proc. Natl. Acad. Sci. U.S.A. 75: 436–440.PubMedCrossRefGoogle Scholar
  66. Herberman, R. B., 1972, Serological analysis of cell surface antigens of tumors induced by mucine leukemia virus, J. Natl. Cancer Inst. 48: 265–271.PubMedGoogle Scholar
  67. Herberman, R. B., and Holden H. T., 1978, Natural cell-mediated immunity, Cancer Res. 27: 305–377.CrossRefGoogle Scholar
  68. Herberman, R. B., Aoki, T., Nunn, M., Laurin, D. H., Soares, N., Gazdar, A., Holden, H., and Chang, K. S. S., 1974, Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus, J. Natl. Cancer Inst. 53: 1103–1111.PubMedGoogle Scholar
  69. Herberman, R. B., Nunn, M. E., and Lavrin, D. H., 1975, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity, Int. J. Cancer 16: 216–229.PubMedCrossRefGoogle Scholar
  70. Holliday, R., Huschtscha, L. I., Tarrant, G. M., and Kirkwood, T. B. L., 1977, Testing the commitment of theory of cellular aging, Science 198: 366–372.PubMedCrossRefGoogle Scholar
  71. Holub, M., Rossman, P., Tsaskolova, H., and Vidmarova, H., 1975, Thymus rudiment of the athymic nude mouse, Nature (London) 256: 491–493.CrossRefGoogle Scholar
  72. Howell, N., and Sager, R., 1979, Noncoordinate expression of SV-40 induced transformation and turnorigenicity in mouse cell hybrids, Somatic Cell Genet. 5: 129–143.PubMedCrossRefGoogle Scholar
  73. Humphrey, J., and Doumashkin, R., 1969, The lessons in cell membranes caused by complement, in: Advances in Immunology, Vol. 11 ( F. J. Dixon and H. G. Kunkel, eds.), pp. 75–195, Academic Press, New York.Google Scholar
  74. Ioachim, H. L., Pearse, A., and Keller, S. E., 1977, Antigenic deletion and malignant enhancement induced in lymphoma cells by passage through X-irradiated hosts, Nature (London) 265: 55–57.CrossRefGoogle Scholar
  75. Jonasson, J., Povey, S., and Harris, H., 1977, The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumors derived from them, J. Cell Sci. 24: 217–254.PubMedGoogle Scholar
  76. Kakunaga, T., 1973, A quantitative system for assay of malignant transformation by chemi- cal carcinogens using a clone derived from BALB/3T3, Int. J. Cancer 12: 463–473.PubMedCrossRefGoogle Scholar
  77. Kasai, M., Leclerc, J. C., McVay-Boudreau, L., Shen, F. W., and Cantor, H., 1979, Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo, J. Exp. Med. 149: 1260–1264.Google Scholar
  78. Kakaoka, T., Kobayashi, H., and Sakurai, Y., 1978, Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents, Cancer Res. 38: 1201–1207.Google Scholar
  79. Kiessling, R., and Haller, O., 1978, Natural killer cells in the mouse: An alternative immune surveillance mechanism? in: Contemporary Topics in Immunobiology, Vol. 8 ( N. L. Warner and M. D. Cooper, eds.), pp. 171–201, Plenum Press, New York.CrossRefGoogle Scholar
  80. Kiessling, R., Klein, and Wigzell, H., 1975, “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5: 112.Google Scholar
  81. Kim, U., Baumber, A., Carruthers, C., and Bielat, K., 1975, Immunological escape mechanism in spontaneously metastasizing mammary tumors, Proc. Natl. Acad. Sci. U.S.A. 72: 1012–1016.PubMedCrossRefGoogle Scholar
  82. Kindred, B., 1979, Nude mice in immunology, Prog. Allergy 26: 137–238.PubMedGoogle Scholar
  83. Klein, E., 1969, Hypersensitivity reactions at tumor sits, Cancer Res. 29: 2351–2362.PubMedGoogle Scholar
  84. Klein, G., 1979, Lymphoma development in mice and humans: Diversity of initiation is followed by convergent cytogenetic evolution, Proc. Natl. Acad. Sci. U.S.A. 76: 2442–2446.PubMedCrossRefGoogle Scholar
  85. Knudson, A. G., 1971, Mutation and cancer: Statistical study of retinoblastoma, Proc. Natl. Acad. Sci. U.S.A. 68: 820–823.PubMedCrossRefGoogle Scholar
  86. Knudson, A. G., 1975, Genetic influence in human tumors, in: Cancer, vol. 1 ( F. F. Becker, ed.), pp. 59–74, Plenum Press, New York.Google Scholar
  87. Kolsch, E., Mengersen, P., and Diller, E., 1973, Low dose tolerance preventing tumor immunity, Eur. J. Cancer 9: 879–882.PubMedGoogle Scholar
  88. Kolsch, E., Oberbarnscheidt, J., Bruner, K., and Heuer, J., 1980, The Fc receptor: Its role in the transmission of differentiation signals, Immunol. Rev. 49 (in press).Google Scholar
  89. Kripke, M. L., Lofgreen, J. S., Beard, J., Milburn-Jessup, J., and Fisher, M. S., 1977, In vivo immune response of mice during carcinogenesis by ultraviolet irradiation, J. Natl. Cancer Inst. 59: 1227–1230.Google Scholar
  90. Lake, J. P., and Reed, N. D., 1976, Regulation of the immune response to polyvinyl pyrrolidine: Effects of anti-lymphocyte serum on the response of normal and mice mice, Cell. Immunol. 21: 364–370.PubMedCrossRefGoogle Scholar
  91. Landazuri, M. D., and Herberman, R. B., 1972, Specificity of cellular immune reactivity to virus-induced tumours, Nature (London) New Biology 238: 18.Google Scholar
  92. Langman, R. E., 1978, Cell-mediated immunity and the major histocompatibility complex, Rev. Physiol. Biochem, Pharmacol. 81: 1–37.CrossRefGoogle Scholar
  93. Le Francois, D., Leon, B., and Barski, G., 1976, Comparative study of low-cancer mouse cell line and its high cancer derivative, J. Microscopic Biol. Cell 27: 25–32.Google Scholar
  94. Lennox, E. S., and Sikora, K., 1977, Antigenic changes in the transformed cell, in: Neoplastic Transformation: Mechanisms and Consequences, Life Sciences Research Report (H. Koprowski, ed. ), pp. 197–207.Google Scholar
  95. Lesley, J., Hyman, R., and Dennert, G., 1974, Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation, J. Natl. Cancer Inst. 53: 1759–1765.PubMedGoogle Scholar
  96. Loor, F., and Roelants, G. E., 1974, High frequency of T lineage lymphocytes in nude mouse spleen, Nature (London) 251: 229–230.CrossRefGoogle Scholar
  97. Loor, F., Amstutz, H., Hagg, H., Mayor, L. S., and Roelants, G. E., 1976, T lineage lymphocytes in nude mice born from homozygous nu/nu parents, Eur. J. Immunol. 6: 663665.Google Scholar
  98. Lupulescu, A., 1978, Enhancement of carcinogenesis by prostaglandins, Nature (London) 272: 634–636.CrossRefGoogle Scholar
  99. Luzzati, A. L., and Jacobson, E. B., 1972, Serum immunoglobulin levels in nude mice, Eur. J. ImmunoL 2: 473–474.PubMedCrossRefGoogle Scholar
  100. Mansfield, J. M., Shannon, W. M., Yen, S., and Wallace, J. H., 1977, Production of factors with immunosuppressive activity by a murine lymphoblastoid tumor cell line (39667), Proc. Soc. Exp. Biol. Med. 154: 341–345.PubMedGoogle Scholar
  101. Martin, W. J., and Martin, S. E., 1974, Naturally occuring cytotoxic antitumor antibodies in sera of congenically athymic (nude) mice, Nature (London) 249: 564–565.CrossRefGoogle Scholar
  102. Mengersen, R., Schick, R., and Kolsch, E., 1975, Correlation of “sneaking through” of tumor cells with specific immunological impairment of the host, Eur. J. Immunol. 5: 532–536.PubMedCrossRefGoogle Scholar
  103. Meruelo, D., Nimelstein, S. H., Jones, P. P., Lieberman, H., and McDevitt, H. O., 1978, Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: A possible mechanism for H-2 linked control of virus-induced neoplasia, J. Exp. Med. 147: 470–487.PubMedCrossRefGoogle Scholar
  104. Milo, G. E., and DiPaolo, J. A., 1978, Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment, Nature (London) 275: 130–132.CrossRefGoogle Scholar
  105. Minna, J. D., 1977, Genetic analysis of malignancy using somatic cell hybrids, in: Genetics of Human Cancer ( J. J. Mulsihill, R. W. Miller, and J. F. Fraumeni, eds.), pp. 343–354, Raven Press, New York.Google Scholar
  106. Moller, G., 1974, Tumor associated embryonic antigens, Transplant. Rev. 20: 1.Google Scholar
  107. Mora, P. T., Chang, L., Couvillion, J. M., Kuster, J. M., and McFarland, V. W., 1977, Im-munological selection of tumor cells which have lost SV40 antigen expression, Nature (London) 269: 36–40.CrossRefGoogle Scholar
  108. Outzen, H. C., Custer, R. P., Eaton, G. J., and Prehn, R. T., 1975, Spontaneous and induced tumor incidence in germfree “nude” mice, Reticuloendothelial Soc. 17: 1–9.Google Scholar
  109. Ozer, H., and Jha, K. K., 1977, Malignancy and transformation: Expression in somatic cell hybrids and variants, in: Advances in Cancer Research ( G. Klein and S. Weinhouse, eds.), pp. 53–93, Academic Press, New York.Google Scholar
  110. Parker, L., and Smith, J. R., 1974, Extension of the lifespan of cultured normal diploid cells by vitamin E, Proc. Natl. Acad. Sci. U.S.A. 71: 4763–4767.CrossRefGoogle Scholar
  111. Parmiani, G., Carbone, G., and Prehn, R. T., 1970, In vitro “spontaneous” neoplastic trans-formation of mouse fibroblasts in diffusion chambers, J. Natl. Cancer Inst. 46: 261–268.Google Scholar
  112. Parmiani, G., Carbone, G., and Prehn, R. T., 1972, In vivo and in vitro methylcholanthrene carcinogenesis in diffusion chambers, Tumori 58: 327–332.Google Scholar
  113. Patek, P. Q., Coffins, J. L., and Cohn, M., 1978, Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis, Nature (London) 276: 510–511.CrossRefGoogle Scholar
  114. Peto, R., 1979, Detection of risk of cancer to man, Proc. R. Soc. London Ser. B 205: 111–120.CrossRefGoogle Scholar
  115. Pike, M. C., and Snyderman, R., 1976, Depression of macrophage function by a factor produced by neoplasms: A mechanism for abrogation of immune surveillance, J. Immunol. 117: 1243–1249.PubMedGoogle Scholar
  116. Plescia, O. J., Smith A. H., and Grinwich, D., 1975, Subversion of immune system by tumor cells and role of prostaglandins, Proc. Natl. Acad. Sci. U.S.A. 72: 1848–1851.PubMedCrossRefGoogle Scholar
  117. Poiley, J. A., Schuman, R. F., and Pienta, J. R., 1978, Characterization of normal human embryo cells grown to over 100 population doublings, In Vitro 14: 405–412.PubMedCrossRefGoogle Scholar
  118. Polvsen, C. D., and Rygaard, J., 1971, Heterotransplantation of human adenocarcinoma of the colon and rectum to the mouse mutant nude. A study of nine consecutive transplantations, J. Acta Pathol. Microbiol. Scand. A 79: 159–169.Google Scholar
  119. Prehn, R. T., and Main, J. M., 1956, Lack of immunizing capacity of homologous cells within diffusion chambers, J. Natl. Cancer Inst. 16: 1257–1268.PubMedGoogle Scholar
  120. Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18: 769.PubMedGoogle Scholar
  121. Ramshaw, I. A., Bretscher, P. A., and Parish, C. R., 1976, Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity, Eur. J. Immunol. 6: 674–679.PubMedCrossRefGoogle Scholar
  122. Ramshaw, I. A., Bretscher, P. A., and Parish, C. R., 1977, Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice, Eur. J. Immunol. 7: 180–185.PubMedCrossRefGoogle Scholar
  123. Rapp, H. J., 1973, A guinea pig model for tumor immunology. A summary, in: Immunological Parameters of Host-Tumor Relationships, Vol. II ( D. W. Weiss, ed.), pp. 162–170, Academic Press, New York.Google Scholar
  124. Roder, J. C., Rosen, A., Fenjo, E. M., and Troy, F. A., 1979, Target-effector interactions in the natural killer cell system: Isolation of target structures, Proc. Natl. Acad. Sci. U.S.A. 76: 1405–1409.PubMedCrossRefGoogle Scholar
  125. Rotter, V., and Trainin, N., 1974, Thymus cell population exerting a regulatory function in the immune response of mice to polyvinyl pyrrolidone, Cell. Immunol. 13: 76–86.PubMedCrossRefGoogle Scholar
  126. Rotter, V., and Trainin, N., 1975, Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells, Transplantation 20: 68–74.PubMedCrossRefGoogle Scholar
  127. Rude, E., Wrede, J., and Gundelach, M. L., 1976, Production of IgG antibodies and enhanced response of nude mice to DNP-dextran, J. Immunol. 116: 527–533.PubMedGoogle Scholar
  128. Rygaard, J., 1973, Thymus and Self, pp. 1–193, F.A.D.L., Copenhagen.Google Scholar
  129. Schwartz, R. S., and Andre-Schwartz, J., 1968, Malignant lymphoproliferative diseases: Interactions between immunological abnormalities and oncogenic viruses, in: Annual Review of Medicine ( A. C. DeGraff, ed.), pp. 269–282, Annual Reviews, Palo Alto, Calif.Google Scholar
  130. Sercarz, E. E., Yowell, R. L., and Adorini, L., 1977, Immune response genes control the helper-suppressor balance, in: Immune System: Genetics and Regulation ( E. E. Sercarz, L. A. Herzenberg, and C. F. Fox, eds.), pp. 497–506, Academic Press, New York.Google Scholar
  131. Shin, S., Freedman, V. H., Risser, R., and Pollack, R., 1975, Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro, Proc. Natl. Acad. Sci. U.S.A. 72: 4435–4439.CrossRefGoogle Scholar
  132. Sjogren, H. O., 1964, Studies on specific transplantation resistance to polyoma-virus-induced tumors. I. Transplantation resistance induced by polyoma virus infection, J. Natl. Cancer Inst. 32: 361–374.Google Scholar
  133. Smith, R. T., and Landy, M., 1970, Immune Surveillance, Academic Press, New York.Google Scholar
  134. Smith, R. T., and Landy, M., 1975, Immunobiology of the Tumor Host Relationship, Academic Press, New York.Google Scholar
  135. Spellman, C. W., and Daynes, R. A., 1977, Modification of immunological potential by ultraviolet radiation. II. Generation of suppressor cells in short-term UV-irradiated mice, Transplantation 24: 120–126.PubMedCrossRefGoogle Scholar
  136. Spellman, C. W., and Daynes, R. A., 1978, Ultraviolet light induced murine suppressor lymphocytes dictate specificity of anti-ultraviolet tumor immune responses, Cell. Immunol. 38: 25–34.PubMedCrossRefGoogle Scholar
  137. Stanbridge, E. J., 1976, Suppression of malignancy in human cells, Nature (London) 260: 17–20.CrossRefGoogle Scholar
  138. Stanbridge, E. J., and Wilkinson, J., 1978, Analysis of malignancy in human cells: Malignant and transformed phenotypes are under separate genetic control, Proc. Natl. Acad. Sci. U.S.A. 75: 1466–1469.PubMedCrossRefGoogle Scholar
  139. Stiles, C. D., Desmond, W., Chuman, L. M., Sato, G., and Saier, M. H., Jr., 1976a, Growth control of heterologous tissue culture cells in the congenically athymic nude mouse, Cancer Res. 36: 1353–1360.PubMedGoogle Scholar
  140. Stiles, C. D., Desmond, W., Chuman, L. M., Sato, G., and Saier, M. H., Jr., 1976b, Relationship of cell growth behavior in vitro to tumorigenicity in the athymic nude mouse, Cancer Res. 36: 3300–3305.PubMedGoogle Scholar
  141. Strauss, D., Jonasson, J., and Harris, H., 1976, Growth in vitro of tumor cell X fibroblast hybrids in which malignancy is suppressed, J. Cell Sci. 25: 73–86.Google Scholar
  142. Stutman, O., 1973, Tumor development in immunologically deficient nude mice after exposure to chemical carcinogenesis, in: Proceedings of the First International Workshop on Nude Mice ( J. Rygaard and C. D. Povlsen, eds.), Verlag, Stuttgart.Google Scholar
  143. Stutman, O., 1974, Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice, Science 183: 534–536.Google Scholar
  144. Stutman, O., 1975, Immunodepression and malignancy, Adv. Cancer Res. 22: 261–422.PubMedCrossRefGoogle Scholar
  145. Stutman, O., 1977, Immunological surveillance, in: Origins of Human Cancer ( H. H. Hiatt, J. D. Watson, and J. A. Winsten, eds.), pp. 729–750, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.Google Scholar
  146. Tucker, R. W., Sanford, K. K., Handleman, S. L., and Jones, G. M., 1977, Colony morphology and growth in agarose as tests far spontaneous neoplastic transformation in vitro, Cancer Res. 37: 1571–1579.Google Scholar
  147. Welsh, R. M., 1978, Mouse natural killer cells: Induction, specificity and function, J. Immunol. 121: 1631–1635.PubMedGoogle Scholar
  148. Whittemore, A. S., 1978, Quantitative theories of oncogenesis, in: Advances in Cancer Re-search ( G. Klein and S. Weinhouse, eds.), Vol. 27, pp. 55–88, Academic Press, New York.Google Scholar
  149. Williamson, A. R., and Askonas, B. A., 1972, Senescence of an antibody-forming cell clone, Nature (London) 238: 337–339.CrossRefGoogle Scholar
  150. Zinkernagel, R. M., Althage, A., Adler, B., Blanden, R. V., Davidson, W. F., Kees, U., Dunlop, M. B. C., and Shreffler, D. C., 1977, H-2 restriction of cell-mediated immunity to an intracellular bacterium, J. Exp. Med. 145: 1353–1367.PubMedCrossRefGoogle Scholar
  151. Zinkernagel, R. M., Callahan, G. N., Althage, A., Cooper, S., and Klein, J., 1978a, On the thymus in the differentiation of H-2 self-recognition by T cells: Evidence for dual recognition, J. Exp. Med. 147: 882–896.PubMedCrossRefGoogle Scholar
  152. Zinkernagel, R. M., Callahan, G. N., Althage, A., Cooper, S., Streilein, J. W., and Klein, J., 1978b, The lymphoreticular system in triggering virus-plus-self-specific cytotoxic cells: Evidence for T help, J. Exp. Med. 147: 897.PubMedCrossRefGoogle Scholar
  153. Zinkernagel, R. M., Althage, A., Waterfield, E., Kindred, B., Callahan, G. N., and Pincet, P., 1980a, Restriction specificities, alloreactivity, and allotolerance expressed by T-cells from nude mice reconstituted with H-2 compatible or incompatible thymus grafts, (submitted manuscript).Google Scholar
  154. Zinkernagel, R. M., Welsh, R., Callahan, G., and Althage, A., 1980b, On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras, (submitted manuscript).Google Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • John Leslie Collins
    • 1
  • Paul Q. Patek
    • 1
  • Melvin Cohn
    • 1
  1. 1.Developmental Biology LaboratoryThe Salk Institute for Biological StudiesSan DiegoUSA

Personalised recommendations